CD44 and glioma: Careful and detailed evaluation using a plethora of in vitro and in vivo assays demonstrates penetration of this nano-system across the BBB, and CD44-selective and anti-proliferative effects on human glioma, mediated by the downregulation of CD44 receptor levels and its signaling activity.